Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Stemtech Corporation Backorders Filled
Healthcare & PharmaceuticalCompany Update

Stemtech Corporation Backorders Filled

October 20, 2025 8:30 AM

Stemtech Corporation, the global leader and pioneer in stem cell nutrition, announces core products are available for shipment after overcoming challenges with supply delivery and manufacturing. Stemtech Corporation, a Nevada USA company (OTCQB:STEK). Stemtech Corporation Chairman & CEO, Charles S. Arnold, states "having inventory to fill orders after dealing with supply issues related to tariffs and capital constraints for some of our...

Read more
Health Impact Alliance and Connect America Announce
Healthcare & PharmaceuticalPartnerships

Health Impact Alliance and Connect America Announce "LifelineConnect" to Transform Senior Independence

October 20, 2025 8:00 AM

Health Impact Alliance (HIA) and Connect America today announced a Letter of Intent under which Connect America will grant HIA rights to expand the iconic Lifeline brand across North America, subject to a definitive agreement. The partnership combines Lifeline's 50-year legacy of trusted emergency response with HIA's innovative connected healthcare ecosystem to support senior independence at scale. Under the new brand LifelineConnect, the...

Read more
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
Healthcare & PharmaceuticalCompany Update

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

October 20, 2025 7:45 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solutions, today announced the commercial launch of generic Doxycycline in Canada. This strategic move strengthens the Company's footprint in the Canadian growing antibiotic sector. Doxycycline is now available to pharmacies, hospitals and healthcare providers nationwide. Doxycycline is a broad-spectrum...

Read more
HLTH 2025: 150 Past Attendees and Investors Identify Their Five AI Platform Categories Set to Displace Legacy Health IT in 2026
Healthcare & PharmaceuticalConferences

HLTH 2025: 150 Past Attendees and Investors Identify Their Five AI Platform Categories Set to Displace Legacy Health IT in 2026

October 20, 2025 7:30 AM

Investor attention at HLTH 2025 is consolidating around a focused set of AI platform categories expected to drive the next phase of health IT disruption. Black Book Research surveyed 154 past HLTH attendees and healthcare investors including those with both successful and failed investments using an investor-specific KPI framework to analyze which AI innovations are most likely to outperform in performance, delivery, and displacement potential....

Read more
Peer-Reviewed Journal of Clinical Psychiatry Publishes Mentavi's Online ADHD Diagnostic Evaluation Validation Study
Healthcare & PharmaceuticalCompany Update

Peer-Reviewed Journal of Clinical Psychiatry Publishes Mentavi's Online ADHD Diagnostic Evaluation Validation Study

October 20, 2025 6:00 AM

Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in the peer reviewed Journal of Clinical Psychiatry (JCP). In what is believed to be the first peer-reviewed study of its kind, an asynchronous, online evaluation matched the diagnostic accuracy of a clinician-led interview for adult ADHD. This publication provides the first peer-reviewed evidence base for a fully...

Read more
Bionic Bloom's NEI to Sponsor Cannadelic Global Summit
Healthcare & PharmaceuticalAdvertorial

Bionic Bloom's NEI to Sponsor Cannadelic Global Summit

October 20, 2025 5:00 AM

Bionic Bloom's Neurodivergent Empowerment Institute (NEI) is proud to announce its sponsorship of the upcoming Cannadelic Global Summit, to be held November 9, 2025, at 2201 1st Ave S, St. Petersburg, FL. This premier event fuses cutting-edge psychedelic research with culture, connection, and conscious healing. Dr. Angela Fisher, founder of Bionic Bloom and Chancellor of Sacred Bloom College of Healing Arts, will deliver a TED-style keynote...

Read more
Genflow Biosciences PLC Announces Recognition of Patentability of Claims
Healthcare & PharmaceuticalRegulatory

Genflow Biosciences PLC Announces Recognition of Patentability of Claims

October 20, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), the only publicly listed longevity company in Europe, is pleased to announce that its European patent (No. 22808414.1, Publication No. EP4338267) was officially published in the European Patent Office (EPO) Bulletin on 15 October 2025. The EPO has recognized the patentability of claims of Genflow's Euro-PCT application, marking a major milestone in the Company's...

Read more
Dr. Angela Fisher Wins
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Dr. Angela Fisher Wins "Best Therapist" in Creative Loafing's Best of the Bay Awards for the Second Year in a Row

October 19, 2025 8:15 PM

Bionic Bloom proudly celebrates Dr. Angela Fisher, PhD, for being named Best Therapist in Creative Loafing Tampa Bay's Best of the Bay Awards for the second consecutive year. As founder of Bionic Bloom Wellness Collective, Dr. Fisher has pioneered a new model of integrative mental-health care that blends psychotherapy, psychedelic assisted therapy, neurodivergent empowerment, and holistic wellness. Her leadership has established Bionic Bloom as...

Read more
Bionic Bloom Welcomes Abigail Hagan, MT-BC, Board-Certified Music Therapist Specializing in Neurodivergent Children
Healthcare & PharmaceuticalDiversity, Equity and Inclusion

Bionic Bloom Welcomes Abigail Hagan, MT-BC, Board-Certified Music Therapist Specializing in Neurodivergent Children

October 19, 2025 8:15 PM

Bionic Bloom, the nation's first legal psilocybin therapy and integrative mental-health clinic, proudly announces the addition of Abigail Hagan, MT-BC, to its expanding interdisciplinary team. A board-certified music therapist with extensive experience supporting neurodivergent children, Abigail brings a compassionate, creative, and evidence-informed approach to therapy. At Bionic Bloom's Neurodivergent Empowerment Institute, Abigail will lead...

Read more
Bionic Bloom Launches Dopamine Reset & Reward Center Rewire Program at the Neurodivergent Empowerment Institute
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Bionic Bloom Launches Dopamine Reset & Reward Center Rewire Program at the Neurodivergent Empowerment Institute

October 19, 2025 8:10 PM

Bionic Bloom's Neurodivergent Empowerment Institute (NEI) is proud to announce the launch of its newest neuroscience-based Intensive Outpatient Program (IOP): Dopamine Reset & Reward Center Rewire, running November through December 2025. This innovative, evidence-informed program helps participants retrain the brain's reward system - shifting dopamine away from overstimulation and burnout, toward sustainable motivation, focus, and joy. "Our...

Read more
Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025
Healthcare & PharmaceuticalConferences

Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025

October 19, 2025 8:00 AM

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, October 19-22, 2025, in Atlanta, GA. The details of the presentations are as follows: Late-Breaking Oral Presentation #229: mRNA-1010, an mRNA-Based Influenza Vaccine, is Safe and Efficacious in Adults Aged ≥50 Years: The presented data show the relative...

Read more
Taurus TRT Review 2025: Full Breakdown of Online Testosterone Replacement Therapy, Pricing, and Patient Results
Healthcare & PharmaceuticalAdvertorial

Taurus TRT Review 2025: Full Breakdown of Online Testosterone Replacement Therapy, Pricing, and Patient Results

October 18, 2025 4:22 PM

Disclaimer: The information is for educational purposes only and should not replace professional medical advice. Always consult a licensed healthcare provider before starting, changing, or stopping any prescription or wellness product. Prices, promotions, and refund policies may change, so always verify the latest details directly on the official Taurus Meds website. This article contains affiliate links. If you purchase through these links, a...

Read more
Biden's DEA Wall of Marijuana Dishonor: The DEA Pattern of Corruption Is Now Impossible to Deny, President Trump Fixing
Healthcare & PharmaceuticalCompany Update

Biden's DEA Wall of Marijuana Dishonor: The DEA Pattern of Corruption Is Now Impossible to Deny, President Trump Fixing

October 18, 2025 7:35 AM

For decades, the Drug Enforcement Administration (DEA) preached "law and order." But behind the curtain of press releases and public hearings lay a very different reality - one defined by unconstitutional procedures, ethical breaches, and bureaucratic cruelty that left patients with Huntington's Disease and Multiple Sclerosis waiting years for medicine that Congress already legalized. Now, with a wave of resignations and retirements among its...

Read more
Chemistry of Connection Presented at Cannadelic Global Summit
Healthcare & PharmaceuticalAdvertorial

Chemistry of Connection Presented at Cannadelic Global Summit

October 18, 2025 7:00 AM

What happens in the brain just before we kiss someone for the first time? What if that tension, that openness, that tremble - was the very key to long-term connection? In her upcoming Cannadelic Global Summit keynote, "From Blushing to Bonding: Erotic Neurobiology and the New Language of Love," Dr. Angela Fisher takes the audience into a live, sensory exploration of how the nervous system learns - and unlearns - safety, desire, and trust. Backed...

Read more
Hi Relief Reports 500% Growth in 3 Months, Expands Global Reach to 5 Markets
Healthcare & PharmaceuticalCompany Update

Hi Relief Reports 500% Growth in 3 Months, Expands Global Reach to 5 Markets

October 18, 2025 6:30 AM

The global wellness economy surpassed $5 trillion in 2023 and continues to accelerate, according to Statista. With consumers increasingly choosing natural, lifestyle-oriented products they can buy online, direct-to-consumer brands are scaling quickly to capture demand. Amid this shift, Hi Relief, an e-commerce brand specializing in mineral-based consumer products, today announced a 500% growth rate over the past three months alongside expansion...

Read more
Desert Oasis Healthcare and RadNet Partner to Advance Early Breast Cancer Detection
Healthcare & PharmaceuticalMergers and Acquisitions

Desert Oasis Healthcare and RadNet Partner to Advance Early Breast Cancer Detection

October 17, 2025 6:55 PM

Desert Oasis Healthcare (DOHC) is proud to announce a partnership with RadNet, Inc. (locally known as Desert Advanced Imaging) to offer Enhanced Breast Cancer Detection (EBCD) and improve outcomes for women across the Coachella Valley. Effective immediately, DOHC will cover the full cost of advanced early breast cancer screening technology through its partnership with RadNet. Previously, this technology was available only by paying a $40...

Read more
 UniDoc Announces Amended LIFE Offering
Healthcare & PharmaceuticalFinancing

UniDoc Announces Amended LIFE Offering

October 17, 2025 6:50 PM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T) ("UniDoc" or the "Company") is pleased to announce that further to its previously announced non-brokered private placement LIFE offering (the "Offering") for total gross proceeds of up to $1,500,000, consisting of up to 10,000,000 units of the Company (each, a "Unit") at a price of $0.15 per Unit, the Company has amended the terms of the Offering toinclude a minimum offering amount. The Offering will now...

Read more
Refills Health Review 2025: GLP-1 Weight Loss Program Explained - Pricing, Results, and How It Works
Healthcare & PharmaceuticalAdvertorial

Refills Health Review 2025: GLP-1 Weight Loss Program Explained - Pricing, Results, and How It Works

October 17, 2025 4:10 PM

This article is for informational purposes only and is not intended to diagnose, treat, or prescribe any medical condition. The Refills GLP-1 Weight Loss Program connects users with licensed clinicians who determine eligibility for compounded GLP-1 medications. Individual results may vary. Always consult your healthcare provider before beginning any weight-loss or prescription program. Refills Health offers compounded GLP-1 medications...

Read more
Psyence Group Inc. Announces RSU Grants
Healthcare & PharmaceuticalCompany Update

Psyence Group Inc. Announces RSU Grants

October 17, 2025 4:05 PM

Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that it granted an aggregate of 721,448 restricted share units (each an "RSU") to certain executives, officers, directors and consultants of the Company pursuant to the Company's Amended and Restated Restricted Share Unit Plan, of which one third vests six months after the grant date, another one third after twelve months and the remaining balance after eighteen months. All...

Read more
Short-Term Health IT Winners & Losers: The Black Book Pre-HLTH 2025 Investor Briefing
Healthcare & PharmaceuticalConferences

Short-Term Health IT Winners & Losers: The Black Book Pre-HLTH 2025 Investor Briefing

October 17, 2025 12:30 PM

Ahead of HLTH 2025, a targeted pulse of 154 provider buyers and past HLTH attendees indicates that despite rebrands, M&A, and a flood of recycled ideas seeking capital, three categories are positioned to generate disproportionate enterprise value and near-term displacement in Q1 2026. For investors: venture, growth equity, private equity, and strategics, as well as enterprise HCIT buyers, these findings mark where pilots are converting to...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
A blue background with the word access on it
By Jennifer Hammers • June 14, 2026
Compare ACCESS Newswire vs Cision PR Newswire on pricing, features, reach, and reviews — and why companies are making the switch..
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?